This regulatory focused summary reviews a completed Medipol University trial comparing endoscopic coblation adenoidectomy with traditional methods and outlines potential regulatory and clinical implications.
The study status is completed as of February 19, 2026, and it evaluates three approaches: endoscopic coblation adenoidectomy, cold curettage adenoidectomy, and a coblation assisted adenoidectomy technique. The sponsor of the trial is Medipol University, and the trial is recorded on ClinicalTrials.gov under NCT07417007. Regulators, clinicians, and device developers should watch this record for context when interpreting energy based adenoidectomy data.
What is being studied?
The registry items identify three elements. First a procedure labeled endoscopic coblation adenoidectomy. Second a traditional cold curettage adenoidectomy procedure. Third a coblation assisted adenoidectomy procedure. This arrangement shows competition between a coblation based energy method and a conventional surgical approach. The trial sponsor is Medipol University and the record indicates completion.
- Endoscopic coblation adenoidectomy
- Cold curettage adenoidectomy
- Coblation assisted adenoidectomy
Public information is available on the ClinicalTrials.gov listing for NCT07417007. You can access the listing at https://clinicaltrials.gov/study/NCT07417007?term=medical+device.
What are the regulatory implications?
With the trial status shown as completed, regulators may review how the described energy based adenoidectomy techniques are framed for intended use and performance. The available public record supports interpretation of the intended purpose and potential performance claims that could appear in regulatory submissions. Statements from the sponsor should be clearly distinguished from study results and be treated as part of the record rather than conclusions themselves.
Intended purpose and performance
The intended purpose is to support removal of adenoidal tissue using an endoscopic energy based method. Device performance will hinge on visualization quality and energy settings. Such parameters influence claims that regulators may evaluate for safety and efficacy.
Safety considerations
Safety signals should be assessed in the context of published data and independent analyses. Because the record does not include final results here, any safety conclusions require corroboration from peer reviewed sources. Regulatory submissions should present sponsor statements separately from results.
What should clinicians know?
Clinicians weighing endoscopic coblation versus traditional adenoidectomy should consider ease of use, visualization, patient selection, and recovery expectations. The trial record shows three intervention types and a completion status, which informs future comparative studies. Clinicians should await detailed results and analyses before changing standard practice.
- 1. What exactly is being studied? The trial compares endoscopic coblation adenoidectomy with cold curettage adenoidectomy and includes a coblation assisted adenoidectomy arm.
- 2. What is the status of the trial? The study is listed as completed in the ClinicalTrials.gov record.
- 3. Where can I access the trial record? The record is on ClinicalTrials.gov at NCT07417007. See https://clinicaltrials.gov/study/NCT07417007?term=medical+device for the listing.
In summary, this completed Medipol trial documents three adenoidectomy approaches and sets the stage for regulatory review of energy based endoscopic devices in this surgical domain. The data may guide safety and performance claims in future submissions while clinicians anticipate full results. Stakeholders should track the official record and look for peer reviewed analyses that clarify comparative benefits and risks.
Important professional disclaimer: this article is for regulatory and clinical professionals. It is not legal advice and does not substitute for regulatory consult. Always reference official regulatory guidance and the primary study record for decisions.
https://clinicaltrials.gov/study/NCT07417007?term=medical+device